GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Piotroski F-Score

Invictus MD Strategies (Invictus MD Strategies) Piotroski F-Score : 0 (As of May. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Invictus MD Strategies has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Invictus MD Strategies's Piotroski F-Score or its related term are showing as below:


Invictus MD Strategies Piotroski F-Score Historical Data

The historical data trend for Invictus MD Strategies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Piotroski F-Score Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Piotroski F-Score
N/A N/A 3.00 4.00 2.00

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.00 2.00 2.00 3.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Oct19) TTM:Last Year (Oct18) TTM:
Net Income was -10.683 + -3.47 + -9.419 + -4.998 = $-28.57 Mil.
Cash Flow from Operations was -5.662 + -2.811 + -1.014 + -1.358 = $-10.85 Mil.
Revenue was 2.74 + 1.2 + 1.882 + 0.636 = $6.46 Mil.
Gross Profit was 0.855 + 0.918 + 0.397 + 0.187 = $2.36 Mil.
Average Total Assets from the begining of this year (Oct18)
to the end of this year (Oct19) was
(111.306 + 115.72 + 112.843 + 99.928 + 94.687) / 5 = $106.8968 Mil.
Total Assets at the begining of this year (Oct18) was $111.31 Mil.
Long-Term Debt & Capital Lease Obligation was $6.87 Mil.
Total Current Assets was $9.16 Mil.
Total Current Liabilities was $9.53 Mil.
Net Income was 3.388 + -2.395 + -4.625 + -8.31 = $-11.94 Mil.

Revenue was 0.549 + 1.023 + 0.351 + 0.804 = $2.73 Mil.
Gross Profit was 0.21 + 0.443 + 0.123 + 0.2 = $0.98 Mil.
Average Total Assets from the begining of last year (Oct17)
to the end of last year (Oct18) was
(73.266 + 92.885 + 93.099 + 89.365 + 111.306) / 5 = $91.9842 Mil.
Total Assets at the begining of last year (Oct17) was $73.27 Mil.
Long-Term Debt & Capital Lease Obligation was $4.28 Mil.
Total Current Assets was $25.74 Mil.
Total Current Liabilities was $5.38 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Invictus MD Strategies's current Net Income (TTM) was -28.57. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Invictus MD Strategies's current Cash Flow from Operations (TTM) was -10.85. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Oct18)
=-28.57/111.306
=-0.25667978

ROA (Last Year)=Net Income/Total Assets (Oct17)
=-11.942/73.266
=-0.16299511

Invictus MD Strategies's return on assets of this year was -0.25667978. Invictus MD Strategies's return on assets of last year was -0.16299511. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Invictus MD Strategies's current Net Income (TTM) was -28.57. Invictus MD Strategies's current Cash Flow from Operations (TTM) was -10.85. ==> -10.85 > -28.57 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Oct19)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Oct18 to Oct19
=6.865/106.8968
=0.06422082

Gearing (Last Year: Oct18)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Oct17 to Oct18
=4.279/91.9842
=0.04651886

Invictus MD Strategies's gearing of this year was 0.06422082. Invictus MD Strategies's gearing of last year was 0.04651886. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Oct19)=Total Current Assets/Total Current Liabilities
=9.155/9.525
=0.96115486

Current Ratio (Last Year: Oct18)=Total Current Assets/Total Current Liabilities
=25.735/5.38
=4.78345725

Invictus MD Strategies's current ratio of this year was 0.96115486. Invictus MD Strategies's current ratio of last year was 4.78345725. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Invictus MD Strategies's number of shares in issue this year was 124.583. Invictus MD Strategies's number of shares in issue last year was 111.585. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2.357/6.458
=0.36497368

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.976/2.727
=0.35790246

Invictus MD Strategies's gross margin of this year was 0.36497368. Invictus MD Strategies's gross margin of last year was 0.35790246. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Oct18)
=6.458/111.306
=0.05802023

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Oct17)
=2.727/73.266
=0.03722054

Invictus MD Strategies's asset turnover of this year was 0.05802023. Invictus MD Strategies's asset turnover of last year was 0.03722054. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Invictus MD Strategies has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Invictus MD Strategies  (OTCPK:IVITF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Invictus MD Strategies Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines